Item 1.01. Entry into a Material Definitive Agreement.
On November 23, 2020, Jiya Acquisition Corp. (the "Company") consummated its
initial public offering ("IPO") of 10,000,000 shares of Class A common stock,
par value $0.0001 per share (the "Shares"). The Shares were sold at a price of
$10.00 per Share, generating gross proceeds to the Company of $100,000,000.
In connection with the IPO, the Company entered into the following agreements,
forms of which were previously filed as exhibits to the Company's Registration
Statement on Form S-1 (File No. 333-249808) for the IPO, initially filed with
the U.S. Securities and Exchange Commission (the "Commission") on November 2,
2020, as amended (the "Registration Statement"):
· An Underwriting Agreement, dated November 18, 2020, between the
Company and Citigroup Global Markets Inc., a copy of which was
previously filed as Exhibit 1.1 to the Current Report on Form 8-K
filed on November 20, 2020 and is incorporated herein by reference.
· A Letter Agreement, dated November 18, 2020, among the Company and
its officers, directors and Jiya Holding Company, LLC, a copy of
which was previously filed as Exhibit 10.1 to the Current Report on
Form 8-K filed on November 20, 2020 and is incorporated herein by
reference.
· An Investment Management Trust Agreement, dated November 18, 2020,
between the Company and Continental Stock Transfer & Trust Company,
as trustee, a copy of which was previously filed as Exhibit 10.2 to
the Current Report on Form 8-K filed on November 20, 2020 and is
incorporated herein by reference.
· A Registration Rights Agreement, dated November 18, 2020, between
the Company and certain security holders, a copy of which was
previously filed as Exhibit 10.3 to the Current Report on Form 8-K
filed on November 20, 2020 and is incorporated herein by reference.
· A Private Placement Purchase Agreement, dated November 18, 2020,
between the Company and Jiya Holding Company LLC, a copy of which
was previously filed as Exhibit 10.4 to the Current Report on Form
8-K filed on November 20, 2020 and is incorporated herein by
reference.
· An Administrative Services Agreement, dated November 18, 2020, by
and between the Company and Jiya Holding Company LLC, a copy of
which was previously filed as Exhibit 10.5 to the Current Report on
Form 8-K filed on November 20, 2020 and is incorporated herein by
reference.
· Indemnity Agreements, each dated November 18, 2020, between the
Company and each of its executive officers and directors, copies of
which were previously filed as Exhibits 10.6 through 10.14 to the
Current Report on Form 8-K filed on November 20, 2020 and are
incorporated herein by reference.
Item 3.02. Unregistered Sales of Equity Securities.
Simultaneously with the closing of the IPO, pursuant to the Private Placement
Purchase Agreement, the Company completed the private sale of an aggregate of
500,000 shares of Class A common stock (the "Private Placement Shares") to Jiya
Holding Company LLC at a purchase price of $10.00 per Private Placement Share,
generating gross proceeds to the Company of $5,000,000. The Private Placement
Shares are identical to the Shares sold in the IPO, except that the Private
Placement Shares, so long as they are held by Jiya Holding Company LLC or its
permitted transferees, (i) may not, subject to certain limited exceptions, be
transferred, assigned or sold by such holders until 30 days after the completion
of the Company's initial business combination, and (ii) will be entitled to
registration rights. No underwriting discounts or commissions were paid with
respect to such sale. The issuance of the Private Placement Warrants was made
pursuant to the exemption from registration contained in Section 4(a)(2) of the
Securities Act of 1933, as amended.
Item 5.02. Departure of Directors or Certain Officers? Election of Directors?
Appointment of Certain Officers? Compensatory Arrangements of
Certain Officers.
On November 18, 2020, in connection with the IPO, Perry Karsen, Dr. Pamela
Klein, Daniel Spiegelman and Dr. Steve Kelsey (the "Directors") were appointed
to the board of directors of the Company (the "Board"). The Directors are
independent directors. Effective November 18, 2020, the Daniel Spiegelman, Perry
Karsen and Dr. Pamela Klein were appointed to the Board's Audit Committee, with
Mr. Spiegelman serving as chair of the Audit Committee. Effective November 18,
2020, Dr. Steve Kelsey, Daniel Spiegelman and Perry Karsen were appointed to the
Board's Compensation Committee, with Mr. Karsen serving as chair of the
Compensation Committee. Effective November 18, 2020, Dr. Steve Kelsey, Daniel
Spiegelman and Dr. Pamela Klein were appointed to the Board's Nominating
Committee, with Dr. Klein serving as chair of the Nominating Committee.
Following the appointment of the Directors, the Board is comprised of the
following three classes: the term of office of the first class of directors,
Class I, consists of Dr. Pamela Klein, Perry Karson and Dr. Steve Kelsey and
will expire at the Company's first annual meeting of stockholders? the term of
office of the second class of directors, Class II, consists of Daniel
Spiegelman, Cory S. Freedland and Rekha Hemrajani and will expire at the
Company's second annual meeting of stockholders? and the term of office of the
third class of directors, Class III, consists of Srinivas Akkaraju and Richard
Van Doren and will expire at the Company's third annual meeting of stockholders.
On November 18, 2020, in connection with their appointments to the Board, each
Director entered into the Letter Agreement as well as an indemnity agreement
with the Company in the forms previously filed as Exhibits 10.1 and 10.5 to the
Registration Statement, respectively. In addition, in November 2020, Jiya
Holding Company LLC, the Company's sponsor, transferred 30,000 shares of Class B
common stock of the Company to each of the Directors for the same per-share
price initially paid by Jiya Holding Company LLC.
Other than the foregoing and the Offer Letter dated as of October 30, 2020 (a
copy of which was filed as Exhibit 10.9 to the Registration Statement and is
incorporated herein by reference), none of the Directors are party to any
arrangement or understanding with any person pursuant to which they were
appointed as directors, nor are they party to any transactions required to be
disclosed under Item 404(a) of Regulation S-K involving the Company.
The foregoing descriptions of the Letter Agreement and the form of indemnity
agreement do not purport to be complete and are qualified in their entireties by
reference to the Letter Agreement and form of indemnity agreement, copies of
which are attached as Exhibit 10.1 hereto and Exhibit 10.5 to the Registration
Statement, respectively, and are incorporated herein by reference.
Item 5.03. Amendments to Certificate of Incorporation or Bylaws.
On November 18, 2020, in connection with the IPO, the Company adopted its First
Amended and Restated Certificate of Incorporation (the "Amended Charter"),
effective the same day. The terms of the Amended Charter are set forth in the
Registration Statement and are incorporated herein by reference. A copy of the
Amended Charter is attached as Exhibit 3.1 hereto and incorporated herein by
reference.
Item 8.01. Other Events.
A total of $100,000,000, comprised of $98,000,000 of the proceeds from the IPO
(which amount includes $3,500,000 of the underwriters' deferred discount) and
$2,000,000 of the proceeds of the sale of the Private Placement Shares, was
placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A. maintained
by Continental Stock Transfer & Trust Company, acting as trustee. Except with
respect to interest earned on the funds held in the trust account that may be
released to the Company to pay its taxes, the funds held in the trust account
will not be released from the trust account until the earliest of (i) the
completion of the Company's initial business combination, (ii) the redemption of
any shares of Class A common stock sold in the IPO ("public shares") properly
submitted in connection with a stockholder vote to amend the Company's Amended
Charter to modify the substance or timing of the Company's obligation to redeem
100% of the public shares if the Company does not complete its initial business
combination within 24 months from the closing of the IPO or with respect to any
other material provisions relating to stockholders' rights or pre-initial
business combination activity and (iii) the redemption of the public shares if
the Company is unable to complete an initial business combination within 24
months from the closing of the IPO, subject to applicable law.
© Edgar Online, source Glimpses